Compound Detail
CHEMBL4565270
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nnc2n1Cc1sc(C#Cc3cnn(CCNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)c3)c(Cc3ccccc3)c1OC2
Basic Information
| ChEMBL ID | CHEMBL4565270 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GLAAFCYBTVEELB-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
686.8
MW (Da)
3.29
ALogP
12
HBA
2
HBD
153.3
PSA (Ų)
0.19
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 9.42
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| RS4-11 | IC50 | = | 0.379 | nM | 9.42 | Growth inhibition of human RS4:11 cells after 96 hrs by CCK8 assay | 30019901 |
| MV4-11 | IC50 | = | 0.47 | nM | 9.33 | Growth inhibition of human MV4-11 cells after 96 hrs by CCK8 assay | 30019901 |
| MOLM-13 | IC50 | = | 2.23 | nM | 8.65 | Growth inhibition of human MOLM13 cells after 96 hrs by CCK8 assay | 30019901 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30019901 | 10.1021/acs.jmedchem.8b00506 | RS4-11 | 2 |
| 30019901 | 10.1021/acs.jmedchem.8b00506 | MV4-11 | 1 |
| 30019901 | 10.1021/acs.jmedchem.8b00506 | MOLM-13 | 1 |
Data from ChEMBL 36 via Core Engine